Literature DB >> 17010964

Hematopoietic potential of the pre-fusion allantois.

Catherine Corbel1, Josselyne Salaün, Patricia Belo-Diabangouaya, Françoise Dieterlen-Lièvre.   

Abstract

We previously showed that the fetal component of the placenta has a vigorous hematopoietic activity. Whether this organ is an environmental niche where hematopoietic stem cells (HSC) proliferate and become committed to various lineages, or whether it is also a site for HSC emergence, was left open. This issue can be addressed only if the components that will give rise to the placenta are tested prior to vascularization. The fetal part of the placenta forms through the fusion of the allantois and the chorionic plate around the stage of 7 somite pairs. The allantois, a mesodermal rudiment that provides fetal blood vessels to the placenta, was retrieved before fusion. We found in this rudiment expression of CD41, a known marker of early embryonic hematopoietic progenitors. c-Kit encoding a progenitor specific receptor was also expressed. Significantly, as early as the 1-2 somite stage, the allantois yielded erythroid, myeloid and multipotent clonogenic progenitors, when pre-cultured in toto prior to seeding in a semisolid medium. These results provide evidence that the allantois has hematopoietic potential per se. Whether this potential also involves the ability to produce HSC is still to be determined.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17010964     DOI: 10.1016/j.ydbio.2006.08.069

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.582


  33 in total

1.  Human placenta and chorion: potential additional sources of hematopoietic stem cells for transplantation.

Authors:  Alicia Bárcena; Marcus O Muench; Mirhan Kapidzic; Matthew Gormley; Gabriel A Goldfien; Susan J Fisher
Journal:  Transfusion       Date:  2011-11       Impact factor: 3.157

Review 2.  Establishment and regulation of the HSC niche: Roles of osteoblastic and vascular compartments.

Authors:  Suleyman Coskun; Karen K Hirschi
Journal:  Birth Defects Res C Embryo Today       Date:  2010-12

3.  Hedgehog signaling in the posterior region of the mouse gastrula suggests manifold roles in the fetal-umbilical connection and posterior morphogenesis.

Authors:  Jacob M Daane; Karen M Downs
Journal:  Dev Dyn       Date:  2011-09       Impact factor: 3.780

4.  STELLA-positive subregions of the primitive streak contribute to posterior tissues of the mouse gastrula.

Authors:  Maria M Mikedis; Karen M Downs
Journal:  Dev Biol       Date:  2011-10-08       Impact factor: 3.582

5.  Ventral embryonic tissues and Hedgehog proteins induce early AGM hematopoietic stem cell development.

Authors:  Marian Peeters; Katrin Ottersbach; Karine Bollerot; Claudia Orelio; Marella de Bruijn; Mark Wijgerde; Elaine Dzierzak
Journal:  Development       Date:  2009-07-01       Impact factor: 6.868

Review 6.  The enigmatic primitive streak: prevailing notions and challenges concerning the body axis of mammals.

Authors:  Karen M Downs
Journal:  Bioessays       Date:  2009-08       Impact factor: 4.345

7.  The human placenta is a hematopoietic organ during the embryonic and fetal periods of development.

Authors:  Alicia Bárcena; Mirhan Kapidzic; Marcus O Muench; Matthew Gormley; Marvin A Scott; Jingly F Weier; Christy Ferlatte; Susan J Fisher
Journal:  Dev Biol       Date:  2008-12-03       Impact factor: 3.582

Review 8.  Erythro-myeloid progenitors: "definitive" hematopoiesis in the conceptus prior to the emergence of hematopoietic stem cells.

Authors:  Jenna M Frame; Kathleen E McGrath; James Palis
Journal:  Blood Cells Mol Dis       Date:  2013-10-02       Impact factor: 3.039

9.  The discovery of a source of adult hematopoietic cells in the embryo.

Authors:  Elaine Dzierzak; Alexander Medvinsky
Journal:  Development       Date:  2008-08       Impact factor: 6.868

Review 10.  Of lineage and legacy: the development of mammalian hematopoietic stem cells.

Authors:  Elaine Dzierzak; Nancy A Speck
Journal:  Nat Immunol       Date:  2008-02       Impact factor: 25.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.